Literature DB >> 11140355

The taurine transporter gene and its role in renal development.

X Han1, A M Budreau, R W Chesney.   

Abstract

This paper examines a unique hypothesis regarding an important role for taurine in renal development. Taurine-deficient neonatal kittens show renal developmental abnormalities, one of several lines of support for this speculation. Adaptive regulation of the taurine transporter gene is critical in mammalian species because maintenance of adequate tissue levels of taurine is essential to the normal development of the retina and the central nervous system. Observations of the remarkable phenotypic similarity that exists between children with deletion of bands p25-pter of chromosome 3 and taurine-deficient kits led us to hypothesize that deletion of the renal taurine transporter gene (TauT) might contribute to some features of the 3p-syndrome. Further, the renal taurine transporter gene is down-regulated by the tumor suppressor gene p53, and up-regulated by the Wilms tumor (WT-1) and early growth response-1 (EGR-1) genes. It has been demonstrated using WT-1 gene knockout mice that WT-1 is critical for normal renal development. In contrast, transgenic mice overexpressing the p53 gene have renal development defects, including hypoplasia similar to that observed in the taurine-deficient kitten. This paper reviews evidence that altered expression of the renal taurine transporter may result in reduced intracellular taurine content, which in turn may lead to abnormal cell volume regulation, cell death and, ultimately, defective renal development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140355     DOI: 10.1007/s007260070002

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  9 in total

1.  Effects of taurine depletion on human placental syncytiotrophoblast renewal and susceptibility to oxidative stress.

Authors:  Michelle Desforges; Hannah Whittaker; Etaoin Farmer; Colin P Sibley; Susan L Greenwood
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Regulation of TauT by cisplatin in LLC-PK1 renal cells.

Authors:  X Han; R W Chesney
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

Review 3.  Taurine and the renal system.

Authors:  Russell W Chesney; Xiaobin Han; Andrea B Patters
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

4.  Functional TauT protects against acute kidney injury.

Authors:  Xiaobin Han; Junming Yue; Russell W Chesney
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

5.  Reduced placental taurine transporter (TauT) activity in pregnancies complicated by pre-eclampsia and maternal obesity.

Authors:  Michelle Desforges; Andrea Ditchfield; Chloe R Hirst; Claire Pegorie; Kathryn Martyn-Smith; Colin P Sibley; Susan L Greenwood
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  High sugar intake via the renin-angiotensin system blunts the baroreceptor reflex in adult rats that were perinatally depleted of taurine.

Authors:  Atcharaporn Thaeomor; J Michael Wyss; Dusit Jirakulsomchok; Sanya Roysommuti
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

7.  Maternal obesity is associated with a reduction in placental taurine transporter activity.

Authors:  A M Ditchfield; M Desforges; T A Mills; J D Glazier; M Wareing; K Mynett; C P Sibley; S L Greenwood
Journal:  Int J Obes (Lond)       Date:  2014-12-30       Impact factor: 5.095

8.  Knockout of the TauT gene predisposes C57BL/6 mice to streptozotocin-induced diabetic nephropathy.

Authors:  Xiaobin Han; Andrea B Patters; Takashi Ito; Junichi Azuma; Stephen W Schaffer; Russell W Chesney
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

Review 9.  Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Maria Goulielmaki; Michalis I Panayiotidis; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.